Femtosecond‑LASIK outcomes using the VisuMax<sup>®</sup>‑MEL<sup>®</sup> 80 platform for hyperopia and hyperopic astigmatism refractive surgery

Tăbăcaru,Bogdana; Stanca,Horia Tudor; Pîrvulescu,Ruxandra Angela; Stanca,Simona; Danielescu,Ciprian; Munteanu,Mihnea; Roșca,Cosmin; Teodoru,Adrian Cosmin

doi:10.3892/etm.2021.9719

March-2021 Volume 21 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2021 Volume 21 Issue 3

Full Size Image

Article Open Access

Femtosecond‑LASIK outcomes using the VisuMax^®‑MEL^® 80 platform for hyperopia and hyperopic astigmatism refractive surgery

Authors:
- Bogdana Tăbăcaru
- Horia Tudor Stanca
- Ruxandra Angela Pîrvulescu
- Simona Stanca
- Ciprian Danielescu
- Mihnea Munteanu
- Cosmin Roșca
- Adrian Cosmin Teodoru
View Affiliations / Copyright

Affiliations: Department of Ophthalmology, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania, Department of Pediatrics, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania, Department of Ophthalmology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi, Romania, Department of Ophthalmology, ‘Victor Babeș’ University of Medicine and Pharmacy, 300041 Timisoara, Romania, Department of Ophthalmology, Oculens Clinic, 400501 Cluj‑Napoca, Romania, Department of Ophthalmology, Faculty of Medicine, ‘Lucian Blaga’ University, 550159 Sibiu, Romania

Copyright: © Tăbăcaru et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 288
|
Published online on: January 26, 2021

https://doi.org/10.3892/etm.2021.9719
Expand metrics +

Abstract

The present study evaluated the efficacy, the safety and the predictability of the Femtosecond laser-assisted in situ keratomileusis (Femto‑LASIK) procedure for hyperopia and hyperopic astigmatism. We retrospectively analyzed the postoperative 12‑month evolution of 593 eyes with hyperopia and hyperopic astigmatism that underwent Femto‑LASIK treatment. The procedure was predictable and effective. No eye lost 2 lines of corrected distance visual acuity (CDVA), demonstrating a safety profile of the procedure. Nine percent of the eyes gained at least one line of CDVA. The accuracy of the spherical equivalent after 12 months was 74% within ±1.0 diopter (D) of emmetropia. The refractive outcomes were stable during the follow‑up period. There were no significant complications during the procedure. Femto‑LASIK using the VisuMax^®‑MEL^® 80 platform was demonstrated to be a suitable option to correct selected cases of hyperopia and hyperopic astigmatism. A longer follow‑up period is required to better assess the refractive results and to detect any further regression.

View Figures

View References

1	Tăbăcaru B: Femtosecond Laser-Excimer Laser Platform for Ametropias Surgery, PhD thesis (no. TD 4697). ‘Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania, 2019.
2	Shah R: History and results; indications and contraindications of SMILE compared with LASIK. Asia Pac J Ophthalmol (Phila). 8:371–376. 2019.PubMed/NCBI View Article : Google Scholar
3	Stanca HT, Munteanu M, Jianu DC, Motoc AG, Jecan CR, Tăbăcaru B, Stanca S and Preda MA: Femtosecond-LASIK outcomes using the VisuMax^®-MEL^® 80 platform for mixed astigmatism refractive surgery. Rom J Morphol Embryol. 59:277–283. 2018.PubMed/NCBI
4	Tabacaru B and Stanca HT: One year refractive outcomes of femtosecond-LASIK in mild, moderate and high myopia. Rom J Ophthalmol. 61:23–31. 2017.PubMed/NCBI View Article : Google Scholar
5	Tabacaru B and Stanca HT: Scheimpflug topographical changes after femtosecond LASIK for mixed astigmatism-theoretical aspects and case study. Rom J Ophthalmol. 61:69–75. 2017.PubMed/NCBI View Article : Google Scholar
6	El-Naggar MT and Hovaghimian DG: Assessment of refractive outcome of femtosecond-assisted LASIK for hyperopia correction. Electron Physician. 9:3958–3965. 2017.PubMed/NCBI View Article : Google Scholar
7	Motwani M and Pei R: Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems. Clin Ophthalmol. 11:999–1007. 2017.PubMed/NCBI View Article : Google Scholar
8	Motwani M: Topographic-guided treatment of hyperopic corrections with a combination of higher order aberration removal with WaveLight^® Contoura and wavefront-optimized hyperopic treatment. Clin Ophthalmol. 12:1021–1029. 2018.PubMed/NCBI View Article : Google Scholar
9	Kanellopoulos AJ: Topography-guided hyperopic and hyperopic astigmatism femtosecond laser-assisted LASIK: Long-term experience with the 400 Hz eye-Q excimer platform. Clin Ophthalmol. 6:895–901. 2012.PubMed/NCBI View Article : Google Scholar
10	Suarez E, Torres F and Duplessie M: LASIK for correction of hyperopia and hyperopia with astigmatism. Int Ophthalmol Clin. 36:65–72. 1996.PubMed/NCBI View Article : Google Scholar
11	Esquenazi S: Five-year follow-up of laser in situ keratomileusis for hyperopia using the Technolas Keracor 117C excimer laser. J Refract Surg. 20:356–363. 2004.PubMed/NCBI
12	Zadok D, Raifkup F, Landau D and Frucht-Pery J: Long-term evaluation of hyperopic laser in situ keratomileusis. J Cataract Refract Surg. 29:2181–2188. 2003.PubMed/NCBI View Article : Google Scholar
13	Jaycock PD, O'Brart DP, Rajan MS and Marshall J: 5-year follow-up of LASIK for hyperopia. Ophthalmology. 112:191–199. 2005.PubMed/NCBI View Article : Google Scholar
14	Varley GA, Huang D, Rapuano CJ, Schallhorn S, Boxer Wachler BS and Sugar A: Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology. LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the American academy of ophthalmology. Ophthalmology. 111:1604–1617. 2004.PubMed/NCBI View Article : Google Scholar
15	Spades L, Sabetti L, D'Alessandri L and Balestrazzi E: Photorefractive keratectomy and LASIK for the correction of hyperopia: 2-year follow-up. J Refract Surg. 22:131–136. 2006.PubMed/NCBI
16	Alió J, Galal A, Ayala MJ and Artola A: Hyperopic LASIK with esiris/schwind technology. J Refract Surg. 22:772–781. 2006.PubMed/NCBI
17	Antonios R, Arba Mosquera S and Awwad ST: Hyperopic laser in situ keratomileusis: Comparison of femtosecond laser and mechanical microkeratome flap creation. J Cataract Refract Surg. 41:1602–1609. 2015.PubMed/NCBI View Article : Google Scholar
18	Desai RU, Jain A and Manche EE: Long-term follow-up of hyperopic laser in situ keratomileusis correction using the Star S2 excimer laser. J Cataract Refract Surg. 34:232–237. 2008.PubMed/NCBI View Article : Google Scholar
19	el-Agha MS, Johnston EW, Bowman RW, Cavanagh HD and McCulley JP: Excimer laser treatment of spherical hyperopia: PRK or LASIK? Trans Am Ophthalmol Soc. 98:59–66. 2000.PubMed/NCBI
20	Zadok D, Maskaleris G, Montes M, Shah S, Garcia V and Chayet A: Hyperopic laser in situ keratomileusis with the Nidek EC-5000 excimer laser. Ophthalmology. 107:1132–1137. 2000.PubMed/NCBI View Article : Google Scholar
21	Davidorf JM, Eghbali F, Onclinx T and Maloney RK: Effect of varying the optical zone diameter on the results of hyperopic laser in situ keratomileusis. Ophthalmology. 108:1261–1265. 2001.PubMed/NCBI View Article : Google Scholar
22	Rashad KM: Laser in situ keratomileusis for the correction of hyperopia from +1.25 to +5.00 diopters with the Technolas Keracor 117C laser. J Refract Surg. 17:113–122. 2001.PubMed/NCBI
23	Llovet F, Galal A, Benitez-del-Castillo JM, Ortega J, Martin C and Baviera J: One-year results of excimer laser in situ keratomileusis for hyperopia. J Cataract Refract Surg. 35:1156–1165. 2009.PubMed/NCBI View Article : Google Scholar
24	Alió JL, El Aswad A, Vega-Estrada A and Javaloy J: Laser in situ keratomileusis for high hyperopia (>5.0 diopters) using optimized aspheric profiles: Efficacy and safety. J Cataract Refract Surg. 39:519–527. 2013.PubMed/NCBI View Article : Google Scholar
25	Kanellopoulos AJ, Conway J and Pe LH: LASIK for hyperopia with the WaveLight excimer laser. J Refract Surg. 22:43–47. 2006.PubMed/NCBI
26	Gil-Cazorla R, Teus MA, de Benito-Llopis L and Mikropoulos DG: Femtosecond laser vs. mechanical microkeratome for hyperopic laser in situ keratomileusis. Am J Ophthalmol. 152:16–21.e2. 2011.PubMed/NCBI View Article : Google Scholar
27	Ditzen K, Fiedler J and Pieger S: Laser in situ keratomileusis for hyperopia and hyperopic astigmatism using the Meditec MEL 70 spot scanner. J Refract Surg. 18:430–434. 2002.PubMed/NCBI
28	Lian J, Ye W, Zhou D and Wang K: Laser in situ keratomileusis for correction of hyperopia and hyperopic astigmatism with the Technolas 117C. J Refract Surg. 18:435–438. 2002.PubMed/NCBI
29	El-Agha MS, Bowman RW, Cavanagh D and McCulley JP: Comparison of photorefractive keratectomy and laser in situ keratomileusis for the treatment of compound hyperopic astigmatism. J Cataract Refract Surg. 29:900–907. 2003.PubMed/NCBI View Article : Google Scholar
30	Pineda-Fernández A, Rueda L, Huang D, Nur J and Jaramillo J: Laser in situ keratomileusis for hyperopia and hyperopic astigmatism with the Nidek EC-5000 excimer laser. J Refract Surg. 17:670–675. 2001.PubMed/NCBI
31	Roesler C and Kohnen T: Changes of functional optical zone after LASIK for hyperopia and hyperopic astigmatism. J Refract Surg. 34:476–481. 2018.PubMed/NCBI View Article : Google Scholar
32	Salz JJ and Stevens CA: LADARVision LASIK Hyperopia Study Group. LASIK correction of spherical hyperopia, hyperopic astigmatism, and mixed astigmatism with the LADARVision excimer laser system. Ophthalmology. 109:1647–1658. 2002.PubMed/NCBI View Article : Google Scholar
33	Tăbăcaru B, Stanca S, Mocanu V, Zemba M, Stanca HT and Munteanu M: Intraoperative flap-related complications in FemtoLASIK surgeries performed with Visumax^® femtosecond laser: A ten-year Romanian experience. Exp Ther Med. 20:2529–2535. 2020.PubMed/NCBI View Article : Google Scholar
34	Stanca TH, Tabacaru B and Celea C: Correlations between confocal microscopy and histological aspects of normal cornea. Rom J Ophthalmol. 59:19–23. 2015.PubMed/NCBI
35	Schallhorn SC, Schallhorn JM, Pelouskova M, Venter JA, Hettinger KA, Hannan SJ and Teenan D: Refractive lens exchange in younger and older presbyopes: Comparison of complication rates, 3 months clinical and patient-reported outcomes. Clin Ophthalmol. 11:1569–1581. 2017.PubMed/NCBI View Article : Google Scholar
36	Mălăescu M, Stanca HT, Tăbăcaru B, Stănilă A, Stanca S and Danielescu C: Accuracy of five intraocular lens formulas in eyes with trifocal lens implant. Exp Ther Med. 20:2536–2543. 2020.PubMed/NCBI View Article : Google Scholar
37	Alió JL, Grzybowski A and Romaniuk D: Refractive lens exchange in modern practice: When and when not to do it? Eye Vis (Lond). 1(10)2014.PubMed/NCBI View Article : Google Scholar
38	Stanca HT, Stanca S, Tabacaru B, Boruga M and Balta F: Bevacizumab in Wet AMD treatment: A tribute to the thirteen years of experience from the beginning of the anti-VEGF era in Romania. Exp Ther Med. 18:4993–5000. 2019.PubMed/NCBI View Article : Google Scholar
39	Goldberg I, Jay Katz L, Mansouri K, Pakravan M and Yazdani S: A refractive surgery candidate with optic nerve head cupping. J Ophthalmic Vis Res. 7:248–256. 2012.PubMed/NCBI
40	Stanca HT, Suvac E, Munteanu M, Jianu DC, Motoc AGM, Roşca GC and Boruga O: Giant cell arteritis with arteritic anterior ischemic optic neuropathy. Rom J Morphol Embryol. 58:281–285. 2017.PubMed/NCBI
41	Moshirfar M, D Wagner W, H Linn S, W Brown T, L Goldberg J, T Gomez A, C Ronquillo Y and C Hoopes P: Corneal refractive surgery in patients with history of optic neuritis. J Ophthalmic Vis Res. 14:436–441. 2019.PubMed/NCBI View Article : Google Scholar
42	Munteanu M, Rosca C and Stanca H: Sub-inner limiting membrane hemorrhage in a patient with Terson syndrome. Int Ophthalmol. 39:461–464. 2019.PubMed/NCBI View Article : Google Scholar
43	Arevalo JF: Managing retinal detachment after refractive surgery: With current knowledge, we cannot determine whether prophylactic treatment is indicated in candidates for refractive surgery. Retina Today. 2017:36–40. 2017.
44	Vatsa S and Sood S: Macular dystrophy in a post LASIK patient. DJO. 30:60–62. 2020.
45	Stanca HT, Munteanu M, Jianu DC, Motoc AGM, Tăbăcaru B, Stanca S, Ungureanu E, Boruga VM and Preda MA: New perspectives in the use of laser diode transscleral cyclophotocoagulation. A prospective single center observational cohort study. Rom J Morphol Embryol. 59:869–872. 2018.PubMed/NCBI
46	Donnenfeld ED: Correcting astigmatism after glaucoma surgery. Glaucoma Today. 2011:29–32. 2011.
47	Preda MA, Karancsi OL, Munteanu M and Stanca HT: Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci. 35:1487–1491. 2020.PubMed/NCBI View Article : Google Scholar
48	Chang JSM, Law AKP, Ng JCM and Cheng MSY: Femtosecond laser in situ keratomileusis flap creation in narrow palpebral fissure eyes without suction. Case Rep Ophthalmol. 8:341–348. 2017.PubMed/NCBI View Article : Google Scholar
49	Boruga O, Bălăşoiu AT, Giuri S, Munteanu M, Stanca HT, Iovănescu G and Preda MA: Caruncular late-onset junctional nevus: Apropos of an anatomo-clinical observation. Rom J Morphol Embryol. 58:1461–1464. 2017.PubMed/NCBI
50	Moshirfar M, Shah TJ, Skanchy DF, Linn SH, Kang P and Durrie DS: Comparison and analysis of FDA reported visual outcomes of the three latest platforms for LASIK: Wavefront guided Visx iDesign, topography guided WaveLight allegro contoura and topography guided Nidek EC-5000 CATz. Clin Ophthalmol. 11:135–147. 2017.PubMed/NCBI View Article : Google Scholar
51	J Shah T, Moshirfar M and C Hoopes P: Safety of the excimer laser in LASIK and PRK for patients with implantable cardiac devices: Our clinical experience in the past two decades. J Ophthalmic Vis Res. 14:530–531. 2019.PubMed/NCBI View Article : Google Scholar
52	Stanca HT, Petrović Z and Munteanu M: Transluminal Nd:YAG laser embolysis-a reasonable method to reperfuse occluded branch retinal arteries. Vojnosanit Pregl. 71:1072–1077. 2014.PubMed/NCBI View Article : Google Scholar
53	Cobo-Soriano R, Beltrán J and Baviera J: LASIK outcomes in patients with underlying systemic contraindications: A preliminary study. Ophthalmology. 113:1118.e1–e8. 2006.PubMed/NCBI View Article : Google Scholar
54	Savoiu Balint G, Iovanescu G, Stanca H, Popoiu CM, Boia E, Popovici RA and Bolintineanu SL: The protective effect of HDL-cholesterol in patients with essential hypertension. Rev Chim. 68:949–952. 2017.
55	Spadea L and Paroli MP: Laser refractive surgery in diabetic patients: A review of the literature. Clin Ophthalmol. 6:1775–1783. 2012.PubMed/NCBI View Article : Google Scholar
56	Reinstein DZ, Archer TJ and Randleman JB: JRS standard for reporting astigmatism outcomes of refractive surgery. J Refract Surg. 30:654–659. 2014.PubMed/NCBI View Article : Google Scholar
57	Waring GO III: Standard graphs for reporting refractive surgery. J Refract Surg. 16:459–466. 2000.PubMed/NCBI
58	Spierer O, Mimouni M, Nemet A, Rabina G and Kaiserman I: Hyperopic laser keratorefractive surgery: Do steep corneas have worse outcomes? Int Ophthalmol. 40:1885–1895. 2020.PubMed/NCBI View Article : Google Scholar

Journals